Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Thursday, August 18, 2022.
Loncar Cancer Immunotherapy ETF (NASDAQ:CNCR)
Bull Market Weakness (+75) - CNCR is showing signs of short-term weakness, but still remains in the confines of a long-term uptrend. Keep an eye on CNCR as it may be in the beginning stages of a reversal.
Is it time to buy, sell, or avoid CNCR?
MarketClub looks at technical strength and momentum to determine if the timing is right for CNCR.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for CNCR
The long-term trend has been UP since Aug 8th, 2022 at 17.05
The intermediate-term trend has been UP since Aug 8th, 2022 at 17.05
The short-term trend has been DOWN since Aug 17th, 2022 at 17.50
Smart Scan Analysis for CNCR
Based on our trend formula, CNCR is rated as a +75 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 17.360 | 17.260 | 17.130 | 17.250 | -0.285 |
| Prev. Close | Volume | Bid | Ask | Time |
| 17.081 | 5871 | 2022-08-17 14:09:07 |
| Year High | 32.32 | Year High Date | 2018-03-13 |
| Year Low | 19.1252 | Year Low Date | 2018-10-29 |
| 52wk High | 31.7 | 52wk High Date | 2021-09-03 |
| 52wk Low | 12.76 | 52wk Low Date | 2022-06-13 |
| Average Volume | 4,097 | Shares Outstanding | 100 |
| Market Cap | 34M | Volatility | 39.81 |